Adrian Merlo
90Y-DOTATOC as a Therapeutic Option for Complex Recurrent or Progressive Meningiomas
Gerster-Gilliéron K, Forrer F, Maecke H, Mueller-Brand J, Merlo A, Cordier D. 90Y-DOTATOC as a Therapeutic Option for Complex Recurrent or Progressive Meningiomas. J Nucl Med 2015; 56:1748-51.
Aug 20, 201590Y-DOTATOC as a Therapeutic Option for Complex Recurrent or Progressive Meningiomas
Aug 20, 2015J Nucl Med 2015; 56:1748-51
Gerster-Gilliéron Karine, Forrer Flavio, Maecke Helmut, Mueller-Brand Jan, Merlo Adrian, Cordier Dominik
Neoadjuvant targeting of glioblastoma multiforme with radiolabeled DOTAGA-substance P--results from a phase I study
Cordier D, Forrer F, Kneifel S, Sailer M, Mariani L, Mäcke H, Müller-Brand J, Merlo A. Neoadjuvant targeting of glioblastoma multiforme with radiolabeled DOTAGA-substance P--results from a phase I study. J Neurooncol 2010; 100:129-36.
Mar 10, 2010Neoadjuvant targeting of glioblastoma multiforme with radiolabeled DOTAGA-substance P--results from a phase I study
Mar 10, 2010J Neurooncol 2010; 100:129-36
Cordier Dominik, Forrer Flavio, Kneifel Stefan, Sailer Martin, Mariani Luigi, Mäcke Helmut, Müller-Brand Jan, Merlo Adrian
Individual voxelwise dosimetry of targeted 90Y-labelled substance P radiotherapy for malignant gliomas
Kneifel S, Bernhardt P, Uusijärvi H, Good S, Plasswilm L, Buitrago-Téllez C, Müller-Brand J, Mäcke H, Merlo A. Individual voxelwise dosimetry of targeted 90Y-labelled substance P radiotherapy for malignant gliomas. Eur J Nucl Med Mol Imaging 2007; 34:1388-95.
Sep 1, 2007Individual voxelwise dosimetry of targeted 90Y-labelled substance P radiotherapy for malignant gliomas
Sep 1, 2007Eur J Nucl Med Mol Imaging 2007; 34:1388-95
Kneifel Stefan, Bernhardt Peter, Uusijärvi Helena, Good Stephan, Plasswilm Ludwig, Buitrago-Téllez Carlos, Müller-Brand Jan, Mäcke Helmut, Merlo Adrian